Afdhal, N., Giannini, E. G., Sigal, S., Muir, A. J., Reddy, K. R., Sheen, I.-S., … Theodore, D. (2012). Improved SVR in a unique cohort of non-cirrhotic thrombocytopenic patients with hepatitis C virus (HCV) treated in the global multicenter ENABLE 1 and 2 trials. In HEPATOLOGY (Vol. 56, pp. 995A-995A). Boston, MA: WILEY-BLACKWELL.

Afdhal, Nezam, Edoardo G. Giannini, Samuel Sigal, Andrew J. Muir, K Rajender Reddy, I-Shyan Sheen, Shanthi Vijayaraghavan, et al. “Improved SVR in a unique cohort of non-cirrhotic thrombocytopenic patients with hepatitis C virus (HCV) treated in the global multicenter ENABLE 1 and 2 trials.” In HEPATOLOGY, 56:995A-995A. WILEY-BLACKWELL, 2012.

Afdhal N, Giannini EG, Sigal S, Muir AJ, Reddy KR, Sheen I-S, et al. Improved SVR in a unique cohort of non-cirrhotic thrombocytopenic patients with hepatitis C virus (HCV) treated in the global multicenter ENABLE 1 and 2 trials. In: HEPATOLOGY. WILEY-BLACKWELL; 2012. p. 995A-995A.

Afdhal, Nezam, et al. “Improved SVR in a unique cohort of non-cirrhotic thrombocytopenic patients with hepatitis C virus (HCV) treated in the global multicenter ENABLE 1 and 2 trials.” HEPATOLOGY, vol. 56, WILEY-BLACKWELL, 2012, pp. 995A-995A.

Afdhal N, Giannini EG, Sigal S, Muir AJ, Reddy KR, Sheen I-S, Vijayaraghavan S, Elkashab M, Romero-Gomez M, Dusheiko G, Iyengar M, Vasey SY, Campbell FM, Theodore D. Improved SVR in a unique cohort of non-cirrhotic thrombocytopenic patients with hepatitis C virus (HCV) treated in the global multicenter ENABLE 1 and 2 trials. HEPATOLOGY. WILEY-BLACKWELL; 2012. p. 995A-995A.